查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1717230

2025年全球定量噴霧吸入器市場報告

Metered Dose Inhaler Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年定量噴霧吸入器市場規模將強勁成長。到 2029 年，這一數字將成長至 202.9 億美元，複合年成長率為 5.5%。預測期內的成長可能是由慢性阻塞性肺病(COPD) 患病率上升、氣喘患病率上升、感染疾病率上升、糖尿病患病率上升以及呼吸系統疾病患病率上升所推動的。預測期內預計的主要趨勢包括技術進步、創新治療方法的開發、監管部門的核准、新吸入器的引入以及在線行銷工具的廣泛使用。

慢性阻塞性肺病(COPD) 盛行率的上升預計將推動定量吸入器 (MDI) 市場的擴張。進行性肺病 (COPD) 是一種以氣流受限為特徵的進行性肺部疾病，通常由長期接觸菸草煙霧等刺激物引起，導致呼吸急促、咳嗽和喘息等症狀。慢性阻塞性肺病病例的增加是由於菸草消費、空氣污染、人口老化以及診斷和治療延遲等因素造成的。 MDI 設備對於治療 COPD 至關重要，它可以將藥物直接輸送到肺部，快速緩解症狀並改善氣流。例如，2023年12月，美國政府機構國立衛生研究院預測，患有慢性阻塞性肺病 (COPD) 的人數將從2030年的5.32億增加到2050年的5.92億。因此，慢性阻塞性肺病 (COPD) 盛行率的上升正在推動定量噴霧吸入器的需求。

定量噴霧吸入器市場的主要企業正專注於開發壓力定量吸入器 (pMDI) 等先進技術，以提高藥物輸送效率並改善患者依從性。 pMDI 是一種使用加壓推進劑以氣霧劑形式釋放特定量藥物的裝置。例如，2023 年 7 月，印度製藥公司 Lupin Limited 在德國推出了 Luforbec 100/6，這是一款用於治療成人氣喘和慢性阻塞性肺病) 的 pMDI。此吸入器將100 μg倍氯米松與6 μgBudesonide結合在一起，為患者提供有效的聯合治療。值得注意的是，Luforbec 的價格比固定參考價格低約 47%，更實惠。由於氣喘影響德國約 5% 的成年人，此產品的推出凸顯了魯賓致力於滿足大量醫療保健需求和改善呼吸照護結果的決心。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 - 市場 - 宏觀經濟情境 宏觀經濟情境包括利率、通膨、地緣政治以及感染疾病和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球定量噴霧吸入器PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球定量噴霧吸入器市場：成長率分析
  • 全球定量噴霧吸入器市場表現：規模與成長，2019-2024
  • 全球定量噴霧吸入器市場預測：規模與成長，2024-2029 年，2034 年
  • 全球定量噴霧吸入器總目標市場（TAM）

第6章市場區隔

  • 全球定量噴霧吸入器市場：按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 桌上型定量噴霧吸入器
  • 可攜式定量噴霧吸入器
  • 其他類型
  • 全球定量噴霧吸入器市場：依通路、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 線上
  • 離線
  • 全球定量噴霧吸入器市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 氣喘
  • 慢性阻塞性肺病
  • 其他用途
  • 全球定量噴霧吸入器市場：依最終用戶、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 居家照護環境
  • 其他最終用戶
  • 全球定量噴霧吸入器市場桌上型定量吸入器細分市場（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 標準桌面 MDI 設備
  • 高效能桌面 MDI 設備
  • 智慧桌面 MDI 設備
  • 全球定量噴霧吸入器市場攜帶式定量吸入器細分市場（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 傳統可攜式MDI 設備
  • 先進的可攜式MDI設備
  • 智慧型可攜式MDI設備
  • 全球定量噴霧吸入器市場，按類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 基於霧化器的MDI設備
  • 乾粉吸入器（DPI）組合裝置
  • 緩霧吸入器（SMI）設備
  • 其他專用 MDI 設備

第7章 區域和國家分析

  • 全球定量噴霧吸入器市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球定量噴霧吸入器市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 定量噴霧吸入器市場：競爭格局
  • 定量噴霧吸入器市場：公司簡介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
    • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
    • 3M Company Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Boehringer Ingelheim GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Berry Global Inc.
  • AptarGroup Inc.
  • Philips Healthcare
  • Chiesi Farmaceutici SpA
  • Cipla Limited
  • Gerresheimer AG
  • Zydus Lifesciences Limited
  • Mylan NV
  • Nemera
  • Beximco Pharmaceuticals Limited
  • Cohero Health Inc.
  • Bespak Europe Ltd.
  • Trudell Medical International

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年定量噴霧吸入器市場：提供新機會的國家
  • 2029年定量噴霧吸入器市場：細分市場帶來新機會
  • 2029年定量噴霧吸入器市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r33808

Metered dose inhalers (MDIs) are medical devices that deliver a specific amount of aerosolized medication directly into the lungs through inhalation. These inhalers are widely used to manage respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and various other lung diseases.

There are several types of metered dose inhaler devices, including desktop metered dose inhalers, portable metered dose inhalers, and others. Desktop metered dose inhalers are fixed devices primarily found in clinical environments, providing a controlled dose of aerosolized medication. These devices are available through both online and offline distribution channels and are commonly used for conditions such as asthma and COPD. They serve a range of end users, including hospitals, clinics, homecare settings, and more.

The metered dose inhaler devices market research report is one of a series of new reports from The Business Research Company that provides metered dose inhaler devices market statistics, including metered dose inhaler devices industry global market size, regional shares, competitors with a metered dose inhaler devices market share, detailed metered dose inhaler devices market segments, market trends and opportunities, and any further data you may need to thrive in the metered dose inhaler devices industry. This metered dose inhaler devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The metered dose inhaler devices market size has grown strongly in recent years. It will grow from $15.46 billion in 2024 to $16.36 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth during the historical period can be attributed to the rising prevalence of diabetes, a higher demand for metered dose inhaler devices, an increase in the number of metered dose inhaler devices, and a growing incidence of chronic obstructive pulmonary disease (COPD).

The metered dose inhaler devices market size is expected to see strong growth in the next few years. It will grow to $20.29 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth during the forecast period can be driven by the growing prevalence of chronic obstructive pulmonary diseases (COPD), the rising incidence of asthma, an increase in infectious diseases, a higher rate of diabetes, and a rise in respiratory diseases. Key trends expected in the forecast period include technological advancements, the development of innovative therapies, regulatory approvals, the introduction of new inhalers, and the widespread use of online marketing tools.

The growing prevalence of chronic obstructive pulmonary diseases (COPD) is expected to drive the expansion of the metered dose inhaler (MDI) devices market. COPD is a progressive lung condition marked by airflow restriction, usually caused by prolonged exposure to irritants such as cigarette smoke, and leads to symptoms such as shortness of breath, coughing, and wheezing. The rise in COPD cases can be attributed to factors such as tobacco consumption, air pollution, an aging population, and delayed diagnosis or treatment. MDI devices are vital in managing COPD by delivering medication directly to the lungs, offering rapid relief and improving airflow. For example, in December 2023, the National Institutes of Health, a US-based government agency, projected that COPD cases would increase from 532 million in 2030 to 592 million by 2050. Consequently, the growing prevalence of COPD is fueling the demand for metered dose inhaler devices.

Leading companies in the metered dose inhaler devices market are concentrating on developing advanced technologies, such as pressurized metered dose inhalers (pMDIs), to boost medication delivery efficiency and increase patient adherence. pMDIs are devices that release a specific dose of medication in aerosol form using a pressurized propellant. For example, in July 2023, Lupin Limited, an India-based pharmaceutical company, introduced Luforbec 100/6, a pMDI aimed at treating adult asthma and chronic obstructive pulmonary disease (COPD) in Germany. This inhaler combines 100 µg of beclometasone and 6 µg of formoterol, offering an effective combination therapy for patients. Notably, Luforbec is priced around 47% below the fixed reference price, making it more affordable. Given that approximately 5% of adults in Germany suffer from asthma, this launch highlights Lupin's dedication to meeting significant healthcare demands and improving respiratory care outcomes.

In March 2022, R-V Industries, Inc., a US-based manufacturer of industrial equipment, acquired MBC Aerosol Inc. for an undisclosed sum. This acquisition is intended to strengthen R-V Industries' aerosol processing and packaging capabilities, broaden its operations beyond Pennsylvania, and support its growth strategy through acquisitions, ensuring greater stability and efficiency across multiple industries. MBC Aerosol Inc. is a US-based manufacturer specializing in the production of metered dose inhalers (MDIs).

Major players in the metered dose inhaler devices market are Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, GlaxoSmithKline plc, 3M Company, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Berry Global Inc., AptarGroup Inc., Philips Healthcare, Chiesi Farmaceutici S.p.A., Cipla Limited, Gerresheimer AG, Zydus Lifesciences Limited, Mylan N.V., Nemera, Beximco Pharmaceuticals Limited, Cohero Health Inc., Bespak Europe Ltd., Trudell Medical International, and Iconovo AB.

North America was the largest region in the metered dose inhaler devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in metered dose inhaler devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the metered dose inhaler devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The metered dose inhaler devices market consists of sales of products including bronchodilators, corticosteroids, combination inhalers, and anticholinergics. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Metered Dose Inhaler Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on metered dose inhaler devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for metered dose inhaler devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The metered dose inhaler devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Desktop Metered Dose Inhaler Devices; Portable Metered Dose Inhaler Devices; Other Types
  • 2) By Distribution Channel: Online; Offline
  • 3) By Application: Asthma; Chronic Obstructive Pulmonary Disease; Other Applications
  • 4) By End-User: Hospitals; Clinics; Homecare Settings; Other End Users
  • Subsegments:
  • 1) By Desktop Metered Dose Inhaler Devices: Standard desktop MDI devices; High-performance desktop MDI devices; Smart desktop MDI devices
  • 2) By Portable Metered Dose Inhaler Devices: Conventional portable MDI devices; Advanced portable MDI devices; Smart portable MDI devices
  • 3) By Other Types: Nebulizer-Based MDI devices; Dry powder inhaler (DPI) combined devices; Soft mist inhaler (SMI) devices; Other specialized MDI devices
  • Companies Mentioned:Pfizer Inc.; Merck & Co. Inc.; AstraZeneca PLC; GlaxoSmithKline plc; 3M Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Metered Dose Inhaler Devices Market Characteristics

3. Metered Dose Inhaler Devices Market Trends And Strategies

4. Metered Dose Inhaler Devices Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Metered Dose Inhaler Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Metered Dose Inhaler Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Metered Dose Inhaler Devices Market Growth Rate Analysis
  • 5.4. Global Metered Dose Inhaler Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Metered Dose Inhaler Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Metered Dose Inhaler Devices Total Addressable Market (TAM)

6. Metered Dose Inhaler Devices Market Segmentation

  • 6.1. Global Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Desktop Metered Dose Inhaler Devices
  • Portable Metered Dose Inhaler Devices
  • Other Types
  • 6.2. Global Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Online
  • Offline
  • 6.3. Global Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Other Applications
  • 6.4. Global Metered Dose Inhaler Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Homecare Settings
  • Other End Users
  • 6.5. Global Metered Dose Inhaler Devices Market, Sub-Segmentation Of Desktop Metered Dose Inhaler Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard desktop MDI devices
  • High-performance desktop MDI devices
  • Smart desktop MDI devices
  • 6.6. Global Metered Dose Inhaler Devices Market, Sub-Segmentation Of Portable Metered Dose Inhaler Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Conventional portable MDI devices
  • Advanced portable MDI devices
  • Smart portable MDI devices
  • 6.7. Global Metered Dose Inhaler Devices Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nebulizer-Based MDI devices
  • Dry powder inhaler (DPI) combined devices
  • Soft mist inhaler (SMI) devices
  • Other specialized MDI devices

7. Metered Dose Inhaler Devices Market Regional And Country Analysis

  • 7.1. Global Metered Dose Inhaler Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Metered Dose Inhaler Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Metered Dose Inhaler Devices Market

  • 8.1. Asia-Pacific Metered Dose Inhaler Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Metered Dose Inhaler Devices Market

  • 9.1. China Metered Dose Inhaler Devices Market Overview
  • 9.2. China Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Metered Dose Inhaler Devices Market

  • 10.1. India Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Metered Dose Inhaler Devices Market

  • 11.1. Japan Metered Dose Inhaler Devices Market Overview
  • 11.2. Japan Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Metered Dose Inhaler Devices Market

  • 12.1. Australia Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Metered Dose Inhaler Devices Market

  • 13.1. Indonesia Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Metered Dose Inhaler Devices Market

  • 14.1. South Korea Metered Dose Inhaler Devices Market Overview
  • 14.2. South Korea Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Metered Dose Inhaler Devices Market

  • 15.1. Western Europe Metered Dose Inhaler Devices Market Overview
  • 15.2. Western Europe Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Metered Dose Inhaler Devices Market

  • 16.1. UK Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Metered Dose Inhaler Devices Market

  • 17.1. Germany Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Metered Dose Inhaler Devices Market

  • 18.1. France Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Metered Dose Inhaler Devices Market

  • 19.1. Italy Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Metered Dose Inhaler Devices Market

  • 20.1. Spain Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Metered Dose Inhaler Devices Market

  • 21.1. Eastern Europe Metered Dose Inhaler Devices Market Overview
  • 21.2. Eastern Europe Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Metered Dose Inhaler Devices Market

  • 22.1. Russia Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Metered Dose Inhaler Devices Market

  • 23.1. North America Metered Dose Inhaler Devices Market Overview
  • 23.2. North America Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Metered Dose Inhaler Devices Market

  • 24.1. USA Metered Dose Inhaler Devices Market Overview
  • 24.2. USA Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Metered Dose Inhaler Devices Market

  • 25.1. Canada Metered Dose Inhaler Devices Market Overview
  • 25.2. Canada Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Metered Dose Inhaler Devices Market

  • 26.1. South America Metered Dose Inhaler Devices Market Overview
  • 26.2. South America Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Metered Dose Inhaler Devices Market

  • 27.1. Brazil Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Metered Dose Inhaler Devices Market

  • 28.1. Middle East Metered Dose Inhaler Devices Market Overview
  • 28.2. Middle East Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Metered Dose Inhaler Devices Market

  • 29.1. Africa Metered Dose Inhaler Devices Market Overview
  • 29.2. Africa Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Metered Dose Inhaler Devices Market Competitive Landscape And Company Profiles

  • 30.1. Metered Dose Inhaler Devices Market Competitive Landscape
  • 30.2. Metered Dose Inhaler Devices Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. 3M Company Overview, Products and Services, Strategy and Financial Analysis

31. Metered Dose Inhaler Devices Market Other Major And Innovative Companies

  • 31.1. Boehringer Ingelheim GmbH
  • 31.2. Teva Pharmaceutical Industries Ltd.
  • 31.3. Berry Global Inc.
  • 31.4. AptarGroup Inc.
  • 31.5. Philips Healthcare
  • 31.6. Chiesi Farmaceutici S.p.A.
  • 31.7. Cipla Limited
  • 31.8. Gerresheimer AG
  • 31.9. Zydus Lifesciences Limited
  • 31.10. Mylan N.V.
  • 31.11. Nemera
  • 31.12. Beximco Pharmaceuticals Limited
  • 31.13. Cohero Health Inc.
  • 31.14. Bespak Europe Ltd.
  • 31.15. Trudell Medical International

32. Global Metered Dose Inhaler Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Metered Dose Inhaler Devices Market

34. Recent Developments In The Metered Dose Inhaler Devices Market

35. Metered Dose Inhaler Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Metered Dose Inhaler Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Metered Dose Inhaler Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Metered Dose Inhaler Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer